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Introduction: In the present study, we sought to quantify and contrast the secretome and biomechanical properties of
the non-chondrodystrophic (NCD) and chondrodystrophic (CD) canine intervertebral disc (IVD) nucleus pulposus (NP).
Methods: We used iTRAQ proteomic methods to quantify the secretome of both CD and NCD NP. Differential levels of
proteins detected were further verified using immunohistochemistry, Western blotting, and proteoglycan extraction in
order to evaluate the integrity of the small leucine-rich proteoglycans (SLRPs) decorin and biglycan. Additionally, we
used robotic biomechanical testing to evaluate the biomechanical properties of spinal motion segments from both CD
and NCD canines.
Results: We detected differential levels of decorin, biglycan, and fibronectin, as well as of other important extracellular
matrix (ECM)-related proteins, such as fibromodulin and HAPLN1 in the IVD NP obtained from CD canines compared
with NCD canines. The core proteins of the vital SLRPs decorin and biglycan were fragmented in CD NP but were intact
in the NP of the NCD animals. CD and NCD vertebral motion segments demonstrated significant differences, with the
CD segments having less stiffness and a more varied range of motion.
Conclusions: The CD NP recapitulates key elements of human degenerative disc disease. Our data suggest that at least
some of the compromised biomechanical properties of the degenerative disc arise from fibrocartilaginous metaplasia of
the NP secondary to fragmentation of SLRP core proteins and associated degenerative changes affecting the ECM. This
study demonstrates that the degenerative changes that naturally occur within the CD NP make this animal a valuable
animal model with which to study IVD degeneration and potential biological therapeutics.Introduction
Degenerative disc disease (DDD) affects the cellular and
extracellular compartments of the entire intervertebral
disc (IVD), often leading to associated pain and dis-
ability. The specific compartments of the disc affected
by degenerative changes include the inner nucleus pul-
posus (NP), the annulus fibrosus (AF), the transition
zone interposed between the NP and AF, and the verte-
bral end plates (VEPs). All of these components, in* Correspondence: mark.erwin@utoronto.ca
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within the IVD NP, such as proteoglycans, contribute to
the function of the IVD as a hydrophilic, multiaxial,
viscoelastic, and flexible joint between vertebrae [1–3].
Within the IVD NP ECM, the small leucine-rich proteo-
glycans (SLRPs) are involved with fibrillogenesis and
interact and bind growth factors dependent upon the
integrity of their core proteins and functioning glycos-
aminoglycan (GAG) side chains [4].
The non-degenerative NP, with its high water content,
has biomechanical characteristics that are more fluidlike
than those of the more fibrous, degenerative NP (with
inferior hydrophilic properties), which behaves more like
a solid [5]. However, with increasing degeneration, there
is fragmentation of the SLRP core proteins, leading to a
loss of ECM homeostasis, water content, and furtheris distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
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progressive degeneration, although the overall collagen
content remains relatively stable, there is a shift in the
expression of collagen type II to collagen type I within
the nucleus [4, 7–9]. This shift in the secretion of colla-
gen, along with degradation of other ECM proteins
within the NP, may contribute to aberrant biomechanical
properties, pain, reflexive muscular spasm, and disability.
In an effort to mimic human DDD, non-physiologic
perturbations intended to create IVD degeneration, such
as needle puncture, have been developed in animals such
as the rat, mouse, rabbit, pig, sheep, and canine. How-
ever, there are tremendous differences in the morpholo-
gies and cellular phenotypes of the IVDs of many animal
models that bear varying resemblance to the human
condition. However, two subspecies of canine diffe-
rentially develop DDD in the absence of any external
stimulus. Specifically, the chondrodystrophic (CD) ca-
nine (e.g., beagle or dachshund) develops DDD early and
profoundly by the age of 1 year [10]. This is in stark con-
trast to the non-chondrodystrophic (NCD) animal, which
does not develop DDD until much later in life, if at all
[10–13]. Zhou et al. proposed that the histological, radio-
logical, and biochemical changes within the CD animal re-
semble the pathology of human DDD [14, 15]. Notably,
DDD is diagnosed and treated both medically and surgi-
cally the same in dogs as in humans [14].
The gross pathological and biochemical characteristics
(including matrix metalloproteinase [MMP] activity and
GAG content) are similar in canine and human IVD NP,
such that the hallmarks of DDD at different stages (both
dogs and humans) include chondroid cell clusters, dis-
organization of the AF, and increasing appearance of clefts
and cracks of increasing severity [14]. These histological
characteristics are supported by magnetic resonance im-
aging (MRI) scans showing striking similarities between
the appearance of DDD in the different stages of degener-
ation in humans and dogs [14]. However, despite these im-
aging comparisons and assessment of GAG content, most
comparisons are qualitative in nature, and the degenerative
phenotype often ascribed to the CD IVD NP has not been
quantified. In the present study, we used high-throughput
quantitative proteomic analysis to compare the secretome
of the CD canine (beagle) IVD NP (similar to the human
disc) with that of the NCD (mongrel) canine subspecies,
which is analogous to the IVD of a healthy, young human.
We validated our proteomic investigation using Western
blot analysis and immunohistochemical assays for both
NCD and CD canines. After proteoglycan extraction, we
characterized the integrity of the core proteins of the
SLRPs decorin and biglycan obtained from the IVD NP of
these animals. Finally, we quantified and compared the bio-
mechanical properties of spinal motion segments obtained
from both subspecies using robotic biomechanical testing.Methods
Sample collection of NCD and CD intervertebral disc
nucleus pulposus
All procedures involving the sacrifice of the NCD and
CD dogs and tissue handling were carried out in accord-
ance with established animal use protocols at the Uni-
versity Health Network, University of Toronto, ON,
Canada, and in compliance with the regulations of the
Canadian Council on Animal Care. We removed the T5-
L6 spinal motion segments immediately after the ani-
mals were sacrificed, and then we placed all the speci-
mens on ice. All canines used for the study were
between 20 and 24 months of age and equally divided by
sex. For biomechanical studies, the L4-L5 motion seg-
ment was recovered in its entirety, cleared of all soft tis-
sues including ligaments, labeled, and immediately
stored at −80 °C. For proteomic and biochemical ana-
lyses, we performed a wide laminectomy on the remain-
der of the spine using a Stryker saw (Stryker, Kalamazoo,
MI, USA) followed by clearing of all soft tissues. After
the posterior elements were removed, the spine was
washed with Clidox (Pharmacal Research Laboratories,
Waterbury, CT, USA) and Betadine (Purdue Products,
Stamford, CT, USA) and cooled on ice. Thereafter the
discs were incised immediately adjacent to the inferior
end plate with a number 10 -blade, and the NP was
removed in its entirety as per our established methods
[16, 17]. The NP was placed into warmed physiological
phosphate-buffered saline (PBS; 0.1 M, pH 7.4), rinsed,
and then divided for isobaric tags for relative and abso-
lute quantitation (iTRAQ) or immunohistochemical ana-
lysis. We were meticulous in the selection of the IVD
NP used for these experiments, such that all NCD discs
used were of the jellylike, mucoid, translucent appear-
ance and all CD discs appeared fibrocartilaginous and
pulpy, consistent with the degenerative phenotype widely
used to describe this animal. For histological prepar-
ation, the removed IVD NP was fixed in 10 % formalin,
placed in appropriately labeled cassettes, and processed
using 10 % neutral buffered formalin, ascending grades
of ethanol, two changes of the clearing agent xylol, and
infiltrated with three changes of molten paraffin (Para-
plast) for 12 h. After processing, the samples were
placed into an automated embedding unit, and one sam-
ple at a time was moved from its cassette into a metal
mold, appropriately oriented, filled with molten paraffin,
and cooled on a cold plate and then sent for analysis.
Sample processing and iTRAQ labeling
The NP was obtained in its entirety from the IVD of CD
(CD1–CD4; beagle) and NCD (NCD1–NCD4; mongrel)
canines immediately after the dogs were killed as per our
established methods [16]. The IVD NP thus obtained was
washed three times in 1 ml of cold PBS (0.1 M, pH 7.2)
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tor cocktail (Sigma-Aldrich, St. Louis, MO, USA). Next,
the mixture was centrifuged at 15,000×g for 20 minutes,
and the supernatant was collected. The total protein con-
centration was determined using a Bradford-type colori-
metric assay as described elsewhere [18]. For each set,
clarified tissue lysates were individually denatured, alky-
lated, digested with trypsin, and labeled with iTRAQ labels
(SCIEX, Concord, ON, Canada). The sets were grouped as
follows:
 Set 1: iTRAQ label 114: mongrel, M1; iTRAQ label
115: mongrel, M2; iTRAQ label 116: M3; iTRAQ
117: reference sample
 Set 2: iTRAQ label 114: mongrel, M4; iTRAQ label
115: beagle, B1; iTRAQ label 116: reference sample;
iTRAQ label 117: beagle, B2
 Set 3: iTRAQ label 114: beagle, B3; iTRAQ label
115: reference sample; iTRAQ label 116: beagle, B4
The reference sample consisted of equal amounts of
total protein from each of the eight samples used in this
study, thereby providing a global reference that was
common to all three sets. We randomized the labeling
of the reference sample in each set to prevent any inad-
vertent introduction of labeling bias. We then pooled
the labeled samples to form three 4-plex iTRAQ sets.
Mass spectrometry and data analysis
Each iTRAQ set was processed by two-dimensional li-
quid chromatography–tandem mass spectrometry ana-
lysis as described earlier [18]. Briefly, the samples were
separated offline using strong cation exchange (SCX)
chromatography and fractionated into 30 SCX fractions.
Each of these SCX fractions was then dried and redis-
solved in a minimal volume (20–30 μl) of 0.1 % formic
acid. The redissolved fractions were injected into a
reversed-phase (RP) trap column, where they were de-
salted before being eluted into an analytical nano liquid
chromatography (LC) RP column (75-μm internal diam-
eter (i.d.) × 150 mm). Elution and separation on the nano
LC column were effected using a binary gradient of water
and acetonitrile with 0.1 % formic acid at a 200 nl/min
flow rate. Eluting peptides were analyzed on a 5600
Triple time-of-flight instrument (SCIEX) in information-
dependent acquisition mode. Each set was analyzed a
minimum of two times, and the resulting MS data were
then analyzed using the ProteinPilot software (v4.0) pack-
age from SCIEX using a mammalian database. A false dis-
covery rate (FDR) was calculated to provide a measure of
confidence in the proteins reported. To minimize redun-
dancy between proteins reported in the three individual
iTRAQ sets and to ensure consistency of reported iso-
forms from one set to the next, the results of the three setswere aligned using a Microsoft Excel-based (Microsoft,
Redmond, WA, USA) protein alignment template as de-
scribed elsewhere [19]. We first generated a master list of
all the proteins identified in this study by performing a
search of the combined data from all three iTRAQ sets
and duplicate runs using ProteinPilot.
Relative quantification of proteins, which was simul-
taneously performed using ProteinPilot, was based on
the areas of the iTRAQ signature ion peaks. Only pep-
tides not shared with other reported proteins (or group)
contribute to the overall ratios reported for the protein.
The overall protein ratios reported represent a weighted
average of the ratios of the contributing unique peptides,
where the weighting factor is determined by the percent-
age error of the individual peptide ratios. Further, the re-
ported ratios were normalized using a factor, termed the
applied bias, that is calculated based on the assumption
that the majority of the proteins being compared between
the samples in a set are expressed at similar levels.
Western blot analysis
As further validation of the iTRAQ data, we chose to
probe the same NP homogenate supernatants from
which we generated samples for iTRAQ for the level of
proteins secreted, as determined in our proteomic exper-
iments. Equal amounts of tissue homogenates from one
representative sample each of NCD and CD NP that was
used for iTRAQ analysis and immunohistochemistry
were subjected to Western blot analysis and probed for
the levels of secreted fibromodulin, biglycan, and hyalur-
onan and proteoglycan link protein 1 (HAPLN1) as add-
itional verification of our iTRAQ results. Briefly, 50 μg
of total protein obtained from IVDs were resolved on
SDS-PAGE gels. Proteins were then electrotransferred
onto polyvinylidene difluoride membranes (Bio-Rad La-
boratories, Hercules, CA, USA). After blocking with 5 %
non-fat powdered milk in Tris-buffered saline (TBS; 0.1
M, pH 7.4), blots were incubated with either rabbit poly-
clonal antibody against fibromodulin (1:1000, catalog
number sc-33772; Santa Cruz Biotechnology, Santa Cruz,
CA, USA), goat polyclonal antibody against biglycan
(1:1000, catalog number sc-27936; Santa Cruz Biotechnol-
ogy), and goat polyclonal antibody against HAPLN1
(1:1000, catalog number sc-46826; Santa Cruz Biotechnol-
ogy) at 4 °C overnight. We used protein lysates obtained
from canine articular cartilage as positive controls. Mem-
branes were incubated with the corresponding secondary
antibody, horseradish peroxidase (HRP)-conjugated rabbit/
goat anti-immunoglobulin G (anti-IgG; Bio-Rad Labora-
tories) diluted 1:10,000 in 1 % bovine serum albumin
(BSA) for 2 h at room temperature. After each step, blots
were washed three times with TBS with Tween 20 (0.1 %).
Protein bands were detected by the enhanced chemilumin-
escence method (GE Healthcare Bio-Sciences, Pittsburgh,
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Little Chalfont, UK).
Histology and immunohistochemistry
To validate the cellular morphology and characteristics of
the discs obtained from both NCD and CD animals, we
stained representative sections of the discs using he-
matoxylin and eosin and Safranin O. We performed im-
munohistochemical analysis for fibromodulin, HAPLN1,
biglycan, decorin, and aggrecan using independent sets of
paraffin-embedded sections of IVD NP from the same ani-
mals used for iTRAQ analysis. In brief, the sections were
deparaffinized in xylene, hydrated in gradient alcohol,
and pretreated in a microwave oven for 10 minutes at
maximum power in Tris–ethylenediaminetetraacetic acid
(EDTA) buffer (0.01 M, pH 9.0, 0.05 % Tween-20) for
antigen retrieval. The sections were incubated with hydro-
gen peroxide (0.3 % vol/vol) in PBS (0.1 M, pH 7.2) for 15
minutes to quench the endogenous peroxidase activity,
followed by blocking with 5 % BSA to preclude non-
specific binding. Thereafter the slides were incubated with
fibromodulin, HAPLN1, biglycan, decorin, and aggrecan
antibodies for 16 h at 4 °C. The primary antibody was de-
tected using the streptavidin–biotin complex with the
Dako LSAB+ kit (Dako Cytomation, Glostrup, Denmark)
and diaminobenzidine as the chromogen. All procedures
were carried out at room temperature unless otherwise
specified. The slides were washed three times after every
step using PBS containing 0.025 % Triton X-100, and
finally the sections were counterstained with Mayer’s
hematoxylin and mounted with DPX mountant (distrene,
plasticizer, and xylene). We replaced the primary antibody
with isotype-specific non-immune goat/rabbit IgG for
negative controls, and all sections were evaluated by light
microscopic examination.
Proteoglycan extraction and SLRP assay
As described above, entire NPs were removed from five
spinal segments of each of three CD and NCD donor
animals, all of which had the same gross morphological
appearance and were within the same age range as the
donors of our iTRAQ samples. Proteoglycans were then
extracted using GuHCl according to the method de-
scribed by Melrose et al. [6, 20]. NCD and CD NP were
diced, weighed (approximately 0.4 g wet weight), and ex-
tracted with 10 volumes of 4 M GuHCl 100 mM acetate
buffer (pH 5.8 containing 20 mM EDTA, 100 mM 6-amino
hexanoic acid, 25 mM benzamidine) for 40 h at 4 °C with
constant end-over-end mixing. The tissue residue was
removed by centrifugation, and the supernatant was
concentrated by ultrafiltration (Amicon Ultra-15, 15 ml,
3000 kDa, catalog number UFC900308; EMD Millipore,
Billerica, MA, USA), dialyzed against three changes of
deionized cold water using a D-Tube Dialyzer Maxi(MWXO 3.5 kDa, catalog number 71508-3; EMD
Millipore) with a fourth overnight dialysis. The dialyzed
extracts were then freeze-dried. The freeze-dried proteo-
glycans thus extracted were dissolved in 2.1 ml of diges-
tion buffer (0.1 M Tris, 0.03 M acetate, pH 6.5) overnight
at 4 °C with constant shaking, and the protein content of
the dissolved extracts was calculated using a Bradford
assay. Briefly, 500 μg of protein from NCD and CD
samples were digested with 1.0 U of chondroitinase ABC
(C3667; Sigma-Aldrich) and 0.05 U of keratinase (G6920;
Sigma-Aldrich) overnight at 37 °C. Next, 30 μg of
total protein obtained from the extracted proteoglycans
(digested and undigested) were mixed with SDS loading
buffer and dithiothreitol, electrophoresed, and visualized
by Western blotting as described above. For the decorin
and biglycan Western blot primary antibodies, we used a
rabbit polyclonal antibody against decorin (1:200, cata-
log number NBP1-57923; Novus Biologicals, Littleton,
CO, USA) and a goat polyclonal antibody against
biglycan (1:200, catalog number sc-27936; Santa Cruz
Biotechnology). The secondary antibodies were both HRP
conjugates. We used a goat anti-rabbit IgG (heavy and light
chains, catalog number (170-6515; Bio-Rad Laboratories)
and a rabbit anti-goat IgG (heavy and light chains, catalog
number#A24452; Life Technologies, Carlsbad, CA, USA),
both used at 1:10,000 dilution.
Biomechanical testing
We harvested the L4-L5 lumbar motion segments from
CD and NCD animals within 1–4 h after they were
sacrificed. These segments were removed from the
spines from which the IVDs were subjected to both
iTRAQ analysis and Western blot analysis. CD and
NCD canines (n=6 samples each) were age-matched
(20–24 months) and had average weights of 10 kg and
14 kg, respectively. Following lumbar segment harvest-
ing, the muscle tissues, intertransverse ligaments, and
supra- and interspinous ligaments were carefully dis-
sected, leaving the posterior joints and the IVD intact.
All segments were kept frozen at −20 °C until testing.
The IVD dimensions of each specimen were measured,
and the cross-sectional areas were calculated. Before
testing, the lumbar segments were thawed at room
temperature, and pilot holes were then drilled into each
VEP. Each hole accommodated two anchor screws (#3 ×
25.3 mm) in the superior L4 end plate and one screw
(#8 × 43 mm) in the inferior L5 end plate, perpendicular
to the middisc plane. Dental stone (Modern Materials;
Heraeus Kulzer, South Bend, IN, USA) was prepared ac-
cording to the manufacturer’s recommendations and
used to cement the segments within 3.5-inch–diameter
plastic pots. The two vertebra composing the motion
segments (inclusive of the intervening IVD) were seated
within opposing pots using a standardized template, and
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tebral body height was covered, leaving the IVD exposed
(Fig. 1). Each segment was kept hydrated with gauze
soaked in isotonic saline and covered in plastic wrap
during tissue preparation, potting, and testing. The pot
containing the caudal vertebra (L5) was fixed to a sta-
tionary crossbeam, and the pot containing the cephalad
vertebra (L4) was fixed to a six-axis load cell (AMTI
MC3A-100, Advanced Mechanical Technology, Water-
town, MA, USA), which in turn was attached rigidly to
the parallel robot (Parallel Robotic Systems, Hampton,
NH, USA). This robot is composed of a rigid platform
suspended by six rigid struts of fixed length. Each strut
was attached to an electromechanical motor that travels
about a circular track to alter the position and/or orienta-
tion of the robot platform and thus the potted motion seg-
ment. Custom computer software (National Instruments,
Austin, TX, USA) was employed to control robot position
and orientation. The resolution of the robot is a function
of the motor performance (0.05 mm with a repeatability
of 0.025 mm; Mikrolar, Hampton, NH, USA), which trans-
lates into a linear resolution of less than 1 μm and an
angular resolution of approximately 0.001 degree [20].
The methodology used for biomechanical testing in-
volved a standardized procedure according to an estab-
lished testing protocol [21, 22]. Specimens were tested
using an unconstrained force control system that per-
mitted the application of a desired load in a specific axis
of motion without any constraints on the segment’s mo-
tion behavior, regardless of the specimen condition (e.g.,
intact, injured) [23]. Specifically, we employed our soft-
ware to position the specimen in a neutral pose (e.g.,
loads and moments in all directions were minimized),
after which a bending moment about all three axes of
movement (i.e., flexion and extension, lateral bending,
and axial rotation) (Fig. 1c) was applied until the mo-
ment obtained from the load cell reached a maximum
predetermined value. When the maximum moment was(a) (b)
Fig. 1 Robotic biomechanical setup for intervertebral disc (IVD) motion segm
platform. c The rotational axis x, y and z reflect the three dimensions of movereached in the positive direction, the direction of rota-
tion was reversed to provide a corresponding negative
moment. Based on preliminary tests conducted in three
additional CD specimens (not included in this study),
maximum moments of newton meters were predeter-
mined for flexion and extension, ±3 Nm for lateral bend-
ing, and ±4.5 Nm for axial rotation [24, 25]. The robot’s
displacement during specimen rotation was recorded
directly through a software query via the robot. This
query and collection of specimen moment and load data
occurred at 200 Hz. Five moment cycles around each
Cartesian axis were performed at 0.1/s. The first two cy-
cles were applied to precondition the specimens and
load deformation data from the last three cycles used in
the statistical analysis [26, 27]. The specimens’ moment
and rotation data were plotted, and specific point dis-
placements were obtained at the neutral position, the
midpoint of the ascending moment, the peak moment,
and the midpoint of the descending moment for both
positive and negative rotations.
Statistical analysis
Before statistical analysis, the biomechanical data were
normalized to the cross-sectional area of the IVDs to ac-
count for any differences in the sizes of the respective
IVDs. We used the Shapiro–Wilk normality test to verify
the normal distribution of data obtained from biomech-
anical testing, and numeric data were represented as the
mean ± standard deviation. We compared normalized
displacement mean values between the CD and NCD
groups using an independent t test, with p < 0.05 consid-
ered statistically significant. The proteomic data are pre-
sented as weighted averages of the ratios of the relevant
peptides (ratio calculated with respect to the reference
standard) as described, and the data were normalized
using the applied bias with β-actin as a normalizing factor.
All proteins and peptides were statistically analyzed within
the iTRAQ analysis software platform (ProteinPilot) after(c)
ents. a and b Potted IVD motion segment mounted upon the robotic
ment afforded by biomechanical testing
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FDR cutoff plus up- or downregulation with respect to the
reference pool of at least 0.5 of greater than 2.0-fold. The
proteins and peptides identified by iTRAQ and their ex-
pression ratios are therefore not directly comparable to
each other.
Results
Identification of differentially secreted proteins in nucleus
pulposus of NCD vs. CD canines
Using a 95 % confidence interval and a cutoff of 1 % glo-
bal FDR, we identified 377 proteins in our comparative
proteomic analysis of proteins secreted within the NP of
the two respective canine species (please see Additional
file 1 Table S1). We expressed the levels of all proteins
in each of the individual samples as ratios relative to the
level of secretion of the same protein in the reference
sample. The use of a common reference sample in all
three sets therefore permitted direct comparisons of pro-
tein expression ratios across the different sets. We se-
lected proteins showing consistent differential secretion
in either the NCD or CD cases that were greater than
twofold relative to the reference pool for further investi-
gation. Following these criteria, our data analysis re-
vealed 13 upregulated protein levels in CD (beagles)
with respect to the reference pool and compared with
the expression ratio of these proteins in the NCD ani-
mals. Interestingly, we observed dramatic differences be-
tween the secretion of a number of proteins critical for
the function of the ECM in the IVD and cartilage. These
included decorin, fibronectin, cartilage oligomeric matrix
protein, cartilage intermediate layer protein, HAPLN1,
biglycan, isoform B of proteoglycan 4, fibromodulin, and
aggrecan core protein (Table 1).
Verification of differential expression of proteins in
nucleus pulposus (CD vs. NCD animals)
We determined the secretion of fibromodulin, HAPLN1,
and biglycan in NCD and CD NP homenates using Western
blot analysis with total protein extracted from articular car-
tilage as a control (see Methods section). We observed in-
creased levels of fibromodulin, biglycan, and HAPLN1 in
CD canines compared with NCD canines (Fig. 2). However,
we were unable to determine the expression of β-actin or
glyceraldehyde 3-phosphate dehydrogenase, used as load-
ing controls in the Western blot experiments, because we
used the same IVD NP homogenate samples for these
Western blot experiments as we did for the iTRAQ experi-
ments. These homogenates were not extracts of total pro-
tein but consisted of supernatants obtained from NP
homogenates in PBS (as outlined above) and therefore
contained insufficient β-actin such as would be obtained
using a total protein lysate sample (as was done with the
articular cartilage controls). We maintained strict controlsover protein quantification (Bradford assays in quadrupli-
cate) and scrupulously loaded the same total protein for
each Western blot experiment. We repeated each experi-
ment at least three times to confirm the protein expression
in CD canines compared with NCD canines. The results of
these analyses were consistent with the iTRAQ data.
Histological and immunohistochemical analysis of
intervertebral discs (CD vs. NCD canines)
We used Safranin-O staining to evaluate proteoglycan con-
tent and distribution throughout the IVD NP and immuno-
histochemical methods to verify the differential expression
of the proteins identified in our iTRAQ analysis (decorin,
biglycan, fibromodulin, HAPLN1, and aggrecan) in IVDs
obtained from beagles and mongrels (n=3 each). Represen-
tative images are shown in Fig. 3. All samples revealed the
same overall morphology without exception. Safranin-O
staining revealed a dramatic difference in appearance, with
the CD NP demonstrating intense staining throughout the
ECM and abundant clusters of chondrocyte-like cells.
The NCD NP, however, revealed abundant physaliferous-
appearing cells with positive Safranin-O staining at the
intercellular spaces. The salient differences between the
two canine subspecies was the abundant cell-free and in-
tense Safranin-O staining within the ECM of the CD NP.
The NCD NP contained a highly cellular NP with intense
Safranin-O staining in the smaller intercellular space, and
there were no chondrocyte-like clusters as seen in the CD
IVD NP (Fig. 3). For all ECM proteins, the NCD canine
IVD NP had a cobweb appearance with intense staining
for all proteins located at the areas tightly between the
cells. Immunostaining with decorin revealed diffuse inter-
cellular staining. Much of the areas that were devoid of
staining for any of the antibodies were contained within
the large NP cells with a physaliferous appearance. This
observation is in contrast to the abundant staining of
these proteins in every CD NP sample. Decorin, biglycan,
and HAPLN1 revealed intense staining within the ECM of
the CD samples, with abundant clusters of small numbers
of cells present within the NP (Fig. 3). Immunostaining
for fibromodulin and aggrecan in the CD NP was less in-
tense than for the other three proteins; however, the ECM
staining was still more intense than that seen in the NCD
NP (Fig. 3). Furthermore, the CD NP stained for aggrecan
revealed intense pericellular immunostaining diffusely
through the ECM that was much less cellular than the
NCD NP. The overall appearance of the CD NP bore a
strong resemblance to a fibrocartilaginous phenotype that
was distinctly different from the NCD canine NP.
SLRP expression in intervertebral disc nucleus pulposus
We hypothesized that the CD IVD NP represents a nat-
urally occurring degenerative phenotype. Therefore, we
extracted proteoglycans from NCD and CD canine NP
Table 1 iTRAQ analysis of differential nucleus pulposus homogenate protein expression in NCD and CD dogs
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species were fragmented, as has been reported to occur
in degenerative human discs [4, 20]. Interestingly, we ob-
served multiple bands demonstrating fragmentation of
the core proteins of decorin (30, 25, 20, 17, and 15 kDa)
and biglycan (37, 28, and 25 kDa) in the CD samples,
whereas the NCD samples were completely intact
(Fig. 4). There was no evidence of non-specific binding
of the antibodies in any samples, and these fragmenta-
tion bands visualized on the Western blots were entirely
in keeping with what has been reported in human de-
generative discs [4].Biomechanical robotic testing and analysis
The average IVD cross-sectional areas were 2.45 cm2 for
the CD specimens and 3.10 cm2 for the NCD specimens.
The averaged moment–rotation curve of CD and NCD
specimens for flexion and extension and axial rotation
movements are depicted in Fig. 5a and b, respectively.Differences observed between moment–rotation curves
are indicative of greater stiffness during flexion and ex-
tension and axial rotational loading in the NCD motion
segments compared with CD motion segments. Speci-
fically, angular displacements in flexion and extension
and axial rotation were significantly reduced (p < 0.05)
in NCD specimens at the midpoint of both ascending
and descending moments as well as at the peak moment
(Table 2). There was no statistically significant difference
between the neutral position displacements (p > 0.05).Discussion
In the present study, we used quantitative proteomic ana-
lysis, immunohistochemistry, Western blot analysis, and
robotic biomechanical analysis to demonstrate salient mo-
lecular and biomechanical differences between the noto-
chordal cell-rich (NCD) and notochordal cell-deficient
(CD) IVD NP. In particular, supernatants developed from
mechanically disrupted CD NP yielded far greater
(b)(a)
Fig. 3 Comparative immunohistochemical analysis of non-chondrodystrop
expression and distribution of decorin, biglycan, fibromodulin, hyaluronan and
matrix (ECM) proteins, the NCD canine intervertebral disc NP reveals a cobwe
the areas tightly between the cells. Immunostaining with decorin reveals diffu
physaliferous-appearing notochordal cells. This presentation is in contrast to t
biglycan, and HAPLN1 reveal intense staining within the ECM, with abundant
ECM staining is less intense than that for the other three proteins, fibromodul
stained for aggrecan reveals intense pericellular immunostaining diffusely thro
Safranin-O staining shows quite intense ECM staining in the CD NP, whereas
acellular ECM areas rich in proteoglycan staining. The overall appearance of th





(iii) HAPLN1 43 kDa 
Fig. 2 Western blots for fibromodulin, biglycan, and hyaluronan
and proteoglycan link protein 1 (HAPLN1) expression in non-
chondrodystrophic (NCD) and chondrodystrophic (CD) canine
nucleus pulposus (NP) homogenates. Lane (i) depicts the expression
of these proteins in articular cartilage used as a control. Lanes (ii)
and (iii) represent the expression of these proteins in intervertebral
disc NP homogenates for CD (beagle) and NCD (mongrel) samples.
It is clear that there is strong expression in both articular cartilage
and CD samples for all three proteins. However, in the NCD samples,
fibromodulin and HAPLN1 are undetectable, and the expression of
biglycan is markedly reduced
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Furthermore, consistent with prior reports concerning de-
generative human discs, we detected fragmentation of the
core proteins of the vital SLRPs decorin and biglycan.
However, within the NP of the NCD animal (just as is the
case with healthy IVD NP), the core proteins of these
same SLRPs were intact and we did not detect any non-
specific binding in any samples. We also demonstrate that
the notochordal cell-rich NCD IVD is stiffer and less vari-
able than the CD IVD NP, which has reduced stiffness and
more variable motion characteristics.
The SLRP family of proteins, including decorin, bigly-
can, and fibromodulin, is of considerable importance in
the function and homeostatic regulation of the NP as
well as articular cartilage. SLRPs facilitate interaction
with fibrillar collagens, regulate fibrillogenesis and se-
quester growth factors such as epithelial growth factor
and transforming growth factor (TGF)-β, in addition to
their interaction with the cytokine tumor necrosis fac-
tor- α [20]. Intact SLRP GAG side chains interact with
ECM proteins and facilitate fibril–fibril interaction, cel-
lular proliferation, matrix adhesion, the modulation of
cell growth, and the protection of the GAG side chains(a) (b)
hic (NCD) and chondrodystrophic (CD) canine nucleus pulposus (NP)
proteoglycan link protein 1 (HAPLN1), and aggrecan. For all extracellular
b appearance, demonstrating intense staining for all proteins located in
se intercellular staining with negative immunostaining within the large,
he abundant staining of these proteins in every CD NP sample. Decorin,
clusters of small numbers of cells present within the NP. Although the
in and aggrecan immunostaining is present. Furthermore, the CD NP
ughout the ECM that is much less cellular than the NCD NP staining.
the NCD sample demonstrates intense intercellular staining without large,
e CD NP bears a strong resemblance to a fibrocartilaginous phenotype
(a) (b)
Fig. 4 Western blots depicting the expression of decorin and biglycan after proteoglycan extraction from non-chondrodystrophic (NCD) and
chondrodystrophic (CD) canine intervertebral disc (IVD) nucleus pulposus (NP). For each Western blot, lane (a) is undigested (U) proteoglycan
extract from NCD (mongrel) and lane (c) is from CD (beagle) canine NP. Lanes (b) and (d) depict the detection of the specific small leucine-rich
proteoglycan (SLRP) indicated above after digestion (D) with chondroitinase ABC and keratinase in NCD canine (lane b) and CD canine (lane d).
a The decorin core protein is visualized appropriately at the 43 kDa molecular weight after digestion (lane b), with a clear, single band found from
NCD NP extracts. NP extracts from CD canines (lane d) reveal fragmentation of decorin with multiple lower molecular weight bands visualized
at 30, 25–20, and 17–15 kDa. b The biglycan core protein provides a clear, single band at the 45 kDa molecular weight in the NCD NP extract;
however, the CD NP extract reveals multiple fragments of the core protein visualized at 37–35, 28, and 25 kDa
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performs a vital function with respect to its interaction
with TGF-β, where decorin-TGF-β binding serves to
provide a tissue reservoir of this ubiquitous growth fac-
tor that is essential for ECM homeostasis [28]. Decorin
is reported to regulate collagen fibrillogenesis and matrix
maintenance via interaction with fibronectin and throm-
bospondin, and its expression increases in cartilaginous
tissues with increased degeneration [28]. TGF-β isFig. 5 Averaged moment–rotation curves during (a) flexion and extension
red) and chondrodystrophic (CD; white) specimens. Differences observed b
during flexion and extension and axial rotation loading in the NCD motionreleased into the ECM upon cleavage and fragmentation
of the decorin core protein, and unbound TGF-β in turn
leads to increased MMP-13 expression, downstream in-
flammation, and accelerated degeneration of the ECM that
are inextricably linked with degenerative disease [6, 20].
Capello et al. [29] reported that NP cells obtained
from CD and NCD canines assemble and process pro-
teoglycans (aggrecan in particular) very differently, in
large part owing to the phenotype of the cell (small,and (b) axial rotation movements for non-chondrodystrophic (NCD;
etween moment–rotation curves are indicative of greater stiffness
segments compared with CD motion segments
Table 2 Analysis of angular displacements during the application of 1 Nm moment in flexion and extension and axial rotation motions
Movement CD canines NCD canines p value 95 % CI
Flexion Zero crossing displacement 0.01° (±0.02) 0.01° (±0.03) 0.850 −0.003, 0.024
Halfway from zero to peak displacement 1.16° (±0.39) 0.73° (±0.16) 0.000 0.584, 0.876
Peak displacement 2.29° (±0.79) 1.44° (±0.33) 0.000 1.150, 1.735
Halfway from peak to zero displacement 1.15° (±0.39) 0.72° (±0.16) 0.000 0.573, 0.866
Extension Zero crossing displacement 0.00° (±0.00) 0.00° (±0.00) 0.753 −0.001, 0.002
Halfway from zero to peak displacement −0.82° (±0.28) −0.44° (±0.19) 0.000 −0.554, −0.220
Peak displacement −1.61° (±0.53) −0.86° (±0.38) 0.000 −1.063, −0.434
Halfway from peak to zero displacement −0.78° (±0.27) −0.43° (±0.20) 0.000 −0.514, −0.185
Right axial rotation Zero crossing displacement 0.00° (±0.01) 0.00° (±0.03) 0.358 −0.002, 0.001
Halfway from zero to peak displacement 0.55° (±0.25) 0.37° (±0.17) 0.016 0.036, 0.334
Peak displacement 1.10° (±0.50) 0.73° (±0.35) 0.017 0.071, 0.663
Halfway from peak to zero displacement 0.55° (±0.25) 0.36° (±0.17) 0.017 0.035, 0.331
Left axial rotation Zero crossing displacement 0.00° (±0.01) 0.00° (±0.00) 0.492 −0.001, 0.001
Halfway from zero to peak displacement −0.60° (±0.20) −0.38° (±0.24) 0.007 −0.374, −0.066
Peak displacement −1.20° (±0.41) −0.73° (±0.48) 0.003 −0.778, −0.172
Halfway from peak to zero displacement −0.56° (±0.21) −0.34° (±0.22) 0.005 −0.366, −0.069
CD chondrodystrophic, CI confidence interval, NCD Non-chondrodystrophic
Statistically significant differences between the NCD and CD motion segments in both flexion and extension and axial rotation motions are observed, indicating
that the CD motion segments incur greater displacement (decreased stiffness) than the NCD motion segments
p < 0.05 was considered significant
Erwin et al. Arthritis Research & Therapy  (2015) 17:240 Page 10 of 13chondrocyte-like, or large notochordal). In the Capello
et al. study, NCD discs that contained predominantly large
notochordal cells (>99 %) were found to synthesize and
distribute low molecular weight proteoglycan aggregates
into the intercellular phase at a much faster (threefold)
rate than did the small NP cells obtained from CD discs,
allowing the aggregates to be formed farther from the cell
surface. However, the CD NP-derived small chondrocyte-
like cells synthesized high molecular weight proteoglycans
that were rapidly assembled as high molecular weight
aggregates within both the pericellular and intercellular
compartments, a phenomenon considered to impose a
tendency for reduced matrix remodeling and repair cap-
acity. We observed that the NCD NP is highly cellular
(predominantly physaliferous-appearing notochordal cells)
with a cobweb-appearing ECM tightly held between the
cells. In contrast, the CD animals contain many small
clusters of cells with intense pericellular staining for
aggrecan, decorin, biglycan, and fibromodulin surround-
ing the cells, as well as large patches of diffusely stained
ECM with a distinctly fibrocartilaginous appearance.
The IVD NP of CD animals has been characterized as de-
generating prematurely compared with NCD animals, and
possible genetic reasons for this advanced aging and degen-
eration have been hypothesized [14, 30]. Furthermore, on
the basis of gross pathology, histology, and MMP activity, it
has been demonstrated that DDD is a common occurrence
in dogs just as it is in humans, with the CD dogsexperiencing these changes much earlier in life [14]. The
GAG content within the NP of CD dogs is less than that
found within NCD dogs, a finding consistent with the pre-
mature degeneration that occurs within this subspecies, just
as are MRI classifications that are strikingly similar to those
in humans, strongly supporting the role of the canine as a
model of human DDD [14]. The relatively high ratio of
ECM proteins in CD NP samples, fragmentation of decorin
and biglycan, and sparse clusters of cells in the CD samples
suggest that, akin to the degenerative human IVD NP, the
CD IVD NP represents a naturally occurring degenerative
phenotype in contrast to the non-degenerative NCD NP
[4]. Further support for this hypothesis is that not all
humans develop DDD as opposed to aging, suggesting an
underlying genetic switch or series of switches that may
predispose some people to DDD [31, 32] The CD canine
may represent a similar genetically predetermined subset of
animals that, like humans, is notochordal cell–deficient and
susceptible to degenerative change [12]. A number of pub-
lished studies have begun to shed some light on possible
genetic susceptibility that could contribute to the develop-
ment of DDD in some people (such as vitamin D receptor,
collagen type XI, and others); however, this area of investi-
gation remains to be elucidated [33–35]. The alternative hy-
pothesis is that the CD IVD, having lost its developmentally
notable notochordal cell population, has assumed a fibro-
cartilaginous phenotype (cartilage like cells) with much
more secreted matrix, and therefore the differences we
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fibrocartilaginous IVD NP. This alternative hypothesis ac-
tually supports an important observation: that the fibro-
cartilaginous IVD NP inclusive of fragmented SLRPs and
labile ECM molecules that are not tightly bound within
the matrix in fact actually epitomize the degenerative NP
phenotype. We strongly feel that our data dovetail with
those reported by Brown et al., who demonstrated the
same fragmented SLRP core proteins in degenerative
human NP that we detected within the CD IVD NP [4].
Furthermore, if this fibrocartilaginous phenotype were
healthy, it would not explain the fragmentation of the
SLRPs or the impaired biomechanics compared with the
NCD animal.
To test our hypothesis that the notochordal cell–rich
IVD NP confers more optimal biomechanical properties
upon the NP, in this study we measured the moment-
rotation response of CD and NCD specimens during the
application of a 1 Nm bending moment around the
flexion and extension and 4.5 Nm around the rotational
axis. The unconstrained force control testing procedure
allowed the application of loads about a specific axis at
the same time as minimizing the loads in the other axes
of movement. The biomechanical results of the current
study showed a statistically significant difference be-
tween the displacements of CD and NCD spines during
flexion and extension and axial rotation movements.
The flexion and extension and axial rotation parameters
of the CD and NCD IVDs in our study indicate that the
more degenerative and fibrocartilaginous CD IVD incurs
greater displacement than does the NCD IVD, which is
highly notochordal, highly hydrated, and non-degenerative.
Our observations using this canine model are in agreement
with the study by Iatridis et al. [5], who observed that
the increase in solidlike behavior of degenerative hu-
man IVDs (compared with the more fluidlike IVD NP
of youthful, non-degenerative discs) and their concomi-
tant decreased hydrostatic pressurization reduced en-
ergy dissipation within the discs examined.
Some limitations when interpreting our present bio-
mechanical results are noteworthy. For example, it is
possible that there could be minor differences in anat-
omy, morphology, and biochemistry between specimens
involved in this study. However, previous studies have
described similar macroscopic morphological, histolo-
gical, and biochemical changes in IVD degeneration in
CD and NCD dogs [14, 36]. Additionally, a decrease in
proteoglycan content in the NP has been considered a
governing factor affecting the dynamic viscoelastic prop-
erties of the entire disc [37]. Importantly, the results of
this study involved the analysis of movements with data
normalized to the IVDs’ cross-sectional area, accounting
for differences in IVD sizes. Therefore, despite the po-
tential differences between CD and NCD spines andIVDs in this study, these are likely to not significantly
impact our results.
Conclusions
The CD canine NP represents a naturally occurring
degenerative phenotype that shares many features of the
degenerative human disc, notably fragmented SLRPs such
as decorin and biglycan, the expression of which likely po-
tentiates further ECM degradation and degeneration of
the IVD. Our data suggest that the compromised bio-
mechanical properties of the degenerative disc arise at
least in part from fibrocartilaginous metaplasia of the NP
secondary to fragmentation of these SLRP core proteins
and the associated loss of ECM homeostasis. These obser-
vations add quantitative proteomic and biomechanical
data that support the use of the dog as an optimal model
with which to study human DDD and the evaluation of
potential biologic therapeutics [14]. This study demon-
strates that the degenerative changes that naturally occur
within the CD NP make this animal a valuable animal
model with which to study IVD degeneration and poten-
tial biologic therapeutics.
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